XNAS: RLMD
Relmada Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently...
Read More
7.17
-0.21
(-2.85%)
1.1M
XNAS Volume
XNAS 14 Apr, 2026 3:45 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Relmada Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..